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Objective: Transient left ventricular dysfunction can occur after hypother-
mic, hyperkalemic cardioplegic arrest and is associated with decreased
b-adrenergic receptor responsiveness. Occupancy of the b-adrenergic
receptor activates adenylate cyclase, which phosphorylates the L-type Ca21
channel–enhancing myocyte contractility. The goal of this study was to
identify potential mechanisms that contribute to the defects in the b-ad-
renergic receptor signaling cascade after cardioplegic arrest. Methods:
Isolated left ventricular porcine myocytes were assigned to one of two
treatment groups: (1) cardioplegic arrest (24 mEq/L K1, 4° C 3 2 hours,
then 5 minutes in 37° C cell media; n 5 130) or (2) normothermic control
(cell media, 37° C 3 2 hours; n 5 222). Myocyte contractility was assessed
at baseline and after either b-adrenergic receptor occupancy (25 nmol/L
isoproterenol [INN: isoprenaline]), activation of adenylate cyclase (0.5
mmol forskolin), or direct activation of the L-type Ca21-channel (10 nmol/L
or 100 nmol/L (–)BayK 8644). Results: Myocyte velocity of shortening
(mm/sec) was increased with b-adrenergic receptor occupancy or direct
adenylate cyclase stimulation compared with baseline in the normothermic
group (187.3 6 6.9, 181.7 6 10.2, and 73.9 6 2.9, respectively; p < 0.0001)
and after cardioplegic arrest (128.6 6 8.9, 124.3 6 9.4, and 46.1 6 2.6,
respectively; p < 0.0001). However, the response after cardioplegic arrest
was significantly reduced compared with normothermic values under all
conditions (p 5 0.012). Direct activation of the L-type Ca21-channel, which
eliminates b-adrenergic receptor–dependent events, increased myocyte
contractility in the normothermic group (161.90 6 12.0, p < 0.0001) and
after cardioplegic arrest (92.78 6 6.8, p < 0.0001), but the positive inotropic
response appeared reduced compared with normothermic control values
(p 5 0.003). Conclusion: These findings suggest that contributory mecha-
nisms for the reduced b-adrenergic receptor–mediated response after
hypothermic, hyperkalemic cardioplegic arrest lie downstream from these
specific components of the transduction pathway and likely include defects
in Ca21 homeostasis, myofilament Ca21 sensitivity, or both. (J Thorac
Cardiovasc Surg 1998;115:190-9)
Hypothermic, hyperkalemic cardioplegic arrest isa common means of providing a quiescent heart
during cardiac surgery. However, after reperfusion
and rewarming, transient left ventricular (LV) dys-
function can occur.1, 2 b-Adrenergic agonists are
commonly administered to improve LV pump func-
tion in the early reperfusion-rewarming period.
Stimulation of the b-adrenergic receptor (b-AR)
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activates adenylate cyclase with resultant production
of cyclic adenosine monophosphate (cAMP). One
of the intracellular events after cAMP production
is phosphorylation of the L-type Ca21 channel.3, 4
Phosphorylation of this channel augments Ca21
current during the excitation-contraction process,
thereby enhancing myocyte contractility. However,
diminished b-adrenergic responsiveness after car-
dioplegic arrest has been previously described.5-7
Schwinn and colleagues6 attributed this decrease to
a desensitization of the b-AR with uncoupling of the
b-AR from the G-protein complex after cardiople-
gic arrest. However, specific intracellular defects
that contribute to this blunted b-adrenergic re-
sponse after cardioplegic arrest and rewarming re-
main unclear.
Accordingly, the overall goal of this study was to
examine the specific downstream intracellular de-
fect(s) in the b-adrenergic signaling cascade after
cardioplegic arrest. Well-documented changes in
systemic loading conditions and neurohormonal sys-
tem activity occur after cardioplegic arrest and
separation from cardiopulmonary bypass.1, 2, 5-9 For
example, a twofold increase in plasma norepineph-
rine has been described to occur in the early period
after cardiopulmonary bypass.9 Thus defining the
relationship between changes in contractile perfor-
mance and specific defects in b-AR transduction
processes in vivo can be problematic. This labora-
tory has previously described an isolated LV myo-
cyte system that simulates cardioplegic arrest and
rewarming.10 By use of this in vitro system, past
studies have demonstrated that the contractile re-
sponse to b-AR stimulation is reduced after car-
dioplegic arrest, consistent with clinical observa-
tions.5-7, 10 Accordingly, this study used this myocyte
model of cardioplegic arrest to examine the rela-
tionship between activation of specific components
of the b-AR signaling pathway and contractile per-
formance.
Methods
The overall goal of this study was to examine the
specific intracellular defect(s) in the b-adrenergic signal-
ing pathway after cardioplegic arrest. This was accom-
plished through pharmacologic dissection of the b-adren-
ergic transduction pathway. Specifically, the contractile
response of isolated myocytes was measured in the pres-
ence of either isoproterenol, a b-AR agonist, the naturally
occurring diterpene, forskolin, shown to directly stimulate
adenylate cyclase,11, 12 or the L-type Ca21 channel agonist,
(–)BayK 864413, 14 under normothermic conditions and
after cardioplegic arrest.
Myocyte isolation. Six age- and weight-matched York-
shire swine were the source of myocytes in the study. All
animals were treated and cared for in accordance with the
National Institutes of Health “Guide for the Care and Use
of Laboratory Animals” (National Research Council,
Washington, D.C., 1996). On the day of the study, the
individual animal was anesthetized with a combination of
diazepam (Valium) (10 mg) and 2.5% isoflurane in oxy-
gen, and a sternotomy was performed. The heart was then
quickly excised and placed in cold (4° C) oxygenated
Krebs solution. The LV free wall encompassing the left
circumflex coronary artery (5 3 5 cm) was dissected free
and the artery was cannulated. This was then used to
Fig. 1. The concentration-dependent effects of the L-type
Ca12 channel agonist, (–)BayK 8644, were determined
with respect to changes in isolated myocyte velocity of
shortening. After steady state measurements, myocyte
function was measured in the presence of (–)BayK 8644
using concentrations of 0.1 nmol/L to 1 mmol/L. At
concentrations of 1 to 100 nmol/L (–)BayK 8644, a
concentration-dependent effect was observed and sub-
jected to regression analysis. The computed effective
concentrations of (–)BayK 8644 that yielded a 50% max-
imal response (EC50) and a maximal or 100% response
(EC100) were 10 nmol/L and 100 nmol/L, respectively. The
effects of these concentrations of (–)BayK 8644 on myo-
cyte contractile performance under normothermic condi-
tions and after simulated cardioplegic arrest are shown in
Table I.
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perfuse the tissue with a modified Krebs solution contain-
ing collagenase (0.5 mg/ml, type II; 273 U/mg; Worthing-
ton Biochemical Corp, Freehold, N.J.) for 20 minutes.
The tissue was then minced, added to an oxygenated
solution containing bovine serum albumin (2%, Sigma
Chemical Co., St. Louis, Mo.), deoxyribonuclease (51
Kunitz units/ml, type IV, Sigma), 400 mmol CaCl2, and
collagenase (0.5 mg/ml) and gently agitated. After 15
minutes, the supernatant was removed, filtered, and the
cells allowed to settle. The liberated myocytes were then
resuspended in standard culture medium (2 mmol/L
Ca21; medium M199, Gibco Laboratories, Grand Island,
N.Y.) and plated on coverslips previously coated with a
laminin/fibronectin matrix (Matrigel, Collaborative Re-
search, Bedford, Mass.).
Isolated myocyte function and analysis. Isolated myo-
cytes were placed into a thermostatically controlled cham-
ber at 37° C and imaged with an inverted microscope
(World Precision Instruments, Sarasota, Fla.). Myocyte
contractions were elicited by field stimulation of the
chamber at 1 Hz (S11, Grass Instruments, Quincy, Mass.)
with a 5 msec pulse width. Contraction data for each
myocyte were recorded from a minimum of 20 consecutive
contractions. Myocyte contractions were imaged by use of
a charge-coupled device, digitized, and input into a com-
puter (80486; Zeos International, Minneapolis, Minn.) for
subsequent analysis, as previously described.10, 15 Param-
eters computed from the digitized contraction profiles
included percent shortening (%), velocity of shortening
(mm/sec), velocity of relengthening (mm/sec), total con-
traction duration (msec), and time to peak contraction
(msec). All parameters were calculated for each contrac-
tion, and the results averaged for all contractions were
observed. In past reports it has been demonstrated that
changes in steady state isolated myocyte contractile func-
tion directly reflect changes in the intrinsic capacity of the
LV myocardium to function against a given load.16 By
means of this isolated myocyte system, this laboratory has
demonstrated that myocytes respond in a predictable
manner to incrementally increased external load in both
normal and failing preparations.17 Thus, although the
isolated myocyte function studies described in this study
were performed under equivalent unloaded conditions, it
is likely that these findings can be translated to intrinsic
myocardial contractile capacity.
L-type Ca21 channel activation with (–)BayK 8644-
dose–dependent effects on myocyte function. Although
the effects of the L-type Ca21 channel agonist (–)BayK
8644 (Research Biochemicals International, Natick,
Mass.) with respect to augmentation of myocyte Ca21
current have been well described,13, 14 the concentration-
dependent effects on myocyte contractile performance
remained undefined. Thus initial dose-response studies
were performed to determine appropriate concentrations
of (–)BayK 8644 to be used in the subsequent cardioplegic
arrest studies. After baseline measurements of contractile
function, measurements were repeated in the presence of
(–)BayK 8644 concentrations ranging from 0.1 nmol/L to
1 mmol/L. To avoid L-type Ca21 channel rundown, myo-
cytes were exposed to only one concentration of (–)BayK
8644, and a minimum of 15 myocytes were examined at
each concentration. The dose-response relation for in-
Table I. Isolated myocyte contractile function in normothermic state and after simulated hypothermic









Normothermic control 5.46 6 0.13 10.88 6 0.27*,0.0001 9.49 6 0.40*,0.0001
Cardioplegic arrest 3.42 6 0.15‡,0.0001 7.52 6 0.53‡,0.0001,* ,0.0001 7.70 6 0.49‡0.0045, *,0.0001
Shortening velocity (mm/sec)
Normothermic control 73.92 6 2.85 187.26 6 6.85*,0.0001 181.73 6 10.15*,0.0001
Cardioplegic arrest 46.07 6 2.63‡,0.0001 128.64 6 8.94‡,0.0001, *,0.0001 124.26 6 9.40‡0.0001, *,0.0001
Relengthening velocity (mm/sec)
Normothermic control 78.46 6 3.87 163.99 6 7.14*,0.0001 170.05 6 10.81*,0.0001
Cardioplegic arrest 43.37 6 2.95‡,0.0001 102.89 6 9.39‡,0.0001, *,0.0001 90.76 6 8.40‡,0.0001, *,0.0001
Time to peak contraction (msec)
Normothermic control 243.81 6 5.17 179.27 6 3.15*,0.0001 199.54 6 5.93*,0.0001
Cardioplegic arrest 251.76 6 5.29 183.50 6 5.69*,0.0001 243.34 6 20.12‡0.0489
Total contraction duration (msec)
Normothermic control 502.50 6 8.17 389.98 6 8.66*,0.0001 469.43 6 19.30
Cardioplegic arrest 512.70 6 8.93 408.34 6 16.82*,0.0001 540.26 6 35.96
Number of observations (n)
Normothermic control 222 108 43
Cardioplegic arrest 130 42 19
Normothermic control 5 37° C oxygenated cell media.
Cardioplegic arrest 5 4° C 24 mEq K1 Ringer’s solution 3 2 hr followed by 5 min rewarming in 37° C oxygenated cell media.
*p , 0.05 versus baseline steady state.
†p , 0.05 versus 10 nmol/L (2)BayK 8644 value.
‡p , 0.05 versus normothermic controls.
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creasing concentrations of (–)BayK 8644 with respect to
myocyte shortening velocity is presented in Fig. 1. These
dose-response data were subjected to log-linear regression
analysis to determine the effective concentration of (–)
BayK 8644, which elicited 50% of maximal response
(EC50) and a maximal or 100% response (EC100). These
computations revealed an EC50 and EC100 for (–)BayK
8644 with respect to myocyte velocity of shortening of 10
nmol/L and 100 nmol/L, respectively. Accordingly, these
concentrations of the L-type Ca21 channel agonist were
used in the experimental protocols described in the fol-
lowing section.
Experimental protocol. Myocytes were randomly as-
signed to one of three treatment groups, hypothermic
cardioplegic arrest, hypothermia alone, or normothermic
control animals. The simulated cardioplegic arrest proto-
col, which has been previously described,10 was performed
by incubating myocytes in a conventional hyperkalemic
crystalloid cardioplegic solution (lactated Ringer’s, 24
mEq/L K1, 30 mEq/L HCO3
2, oxygen tension . 300) for
2 hours at 4° C. The myocytes were then incubated in
37° C cell media for a 5-minute rewarming period before
study. Normothermic control animals were maintained in
37° C cell media and used for comparison. In a final
group, the potential effect of temperature on contractile
performance was examined by maintaining myocytes in
4° C cell media for 2 hours followed by a 5-minute
rewarming period. Myocyte contractile function was ex-
amined at baseline and then measured in the presence of
either 25 nmol/L isoproterenol (INN: isoprenaline), 0.5
mmol/L forskolin, 10 nmol/L (–)BayK 8644, or 100 nmol/L
(–)BayK 8644. Previous dose-response studies have dem-
onstrated that 25 nmol/L isoproterenol (Sigma) and 0.5
mmol/L forskolin (Sigma) elicit maximal effects on myo-
cyte contractility under control conditions.18 Thus these
concentrations were chosen for this study.
Data analysis. In this study, two main treatment effects
were used: cardioplegic arrest and drug treatment. Ac-
cordingly, the initial data analysis was performed using a
two-way analysis of variance (ANOVA) to identify the
main treatment effects and any potential interaction be-
tween the main effects with respect to myocyte contractil-
ity. A multiway ANOVA was then carried out to identify
the specific treatment interventions (i.e., b-adrenergic
occupancy, adenylate cyclase stimulation) on contractile
performance under both normothermic control conditions
and after simulated cardioplegic arrest. If the multiway
ANOVA revealed significant differences, pairwise tests of
individual group means were compared using Bonferro-
ni’s probabilities. All statistical analyses were performed
using standard statistical software programs (BMDP Sta-
tistical Software, Inc., Los Angeles, Calif.). Results are
presented as mean 6 standard error of the mean. Values
p , 0.05 were considered statistically significant.
Results
Indices of steady state myocyte contractile func-
tion under normothermic control conditions and
after b-AR occupancy, adenylate cyclase stimula-
tion, or L-type Ca21 channel activation are summa-
rized in Table I. Myocyte contractility was increased
after b-AR occupancy with isoproterenol and after
direct adenylate cyclase stimulation with forskolin.
For example, myocyte velocity of shortening was
increased by 153% after b-AR occupancy and by
146% after adenylate cyclase stimulation. Direct
activation of the L-type Ca21 channel with (–)BayK
8644 increased myocyte contractility. For example,
velocity of shortening was increased by 62% with 10
nmol/L and 120% with 100 nmol/L, reflecting the
EC50 and EC100 concentrations, respectively. In
myocytes maintained in hypothermic cell culture
media for 2 hours (n 5 59), baseline contractile
function was unchanged after rewarming compared
with normothermic control values. For example,
myocyte velocity of shortening was 79.5 6 4.1 mm/
sec in the hypothermic control group compared with
81.8 6 2.1 mm/sec in the normothermic control
group (p 5 0.6237). Therefore it did not appear that
hypothermic conditions significantly affected myo-
cyte contractility. These results are consistent with a
past report from this laboratory, which demon-
strated that prolonged hypothermia alone had min-
imal effects on myocyte contractile function.10
Cardioplegic arrest and rewarming group.
Steady state myocyte contractile function after car-
dioplegic arrest and rewarming and after b-AR
occupancy, adenylate cyclase stimulation, or L-type





7.68 6 0.40*,0.0001 9.45 6 0.50*,0.0001,†0.0079
5.34 6 0.40‡0.0001, *,0.0001 5.96 6 0.35‡,0.0001, *0.0001
119.41 6 9.01*,0.0001 161.90 6 11.98*,0.0001,*0.0064
75.08 6 7.82‡0.0004, *10.0010 92.78 6 6.77‡,0.0001, *,0.0001
113.92 6 12.72*0.0104 158.15 6 16.97*0.0001,†,0.0417
68.14 6 9.21‡0.0048, *0.0140 71.32 6 6.27‡,0.0001, *0.0002
236.18 6 10.83 219.57 6 8.23*0.0159
273.66 6 13.93‡0.0373 256.12 6 14.77‡0.354
649.99 6 29.68*,0.0001 639.65 6 27.39*,0.0001
642.13 6 23.22*,0.0001 637.21 6 20.87*,0.0001
41 28
37 34
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Baseline myocyte contractile function was reduced
after cardioplegic arrest. For example, myocyte ve-
locity of shortening was reduced by 38% compared
with normothermic control values. The two-way
ANOVA revealed that cardioplegic arrest was a
significant main effect with respect to contractile
function. For example, the F values for myocyte
percent shortening and velocity of shortening were
significant for the main treatment effect of cardio-
plegia (F 5 132.57, F 5 108.35, p , 0.0001, respec-
tively). The two-way ANOVA also demonstrated
that the drug treatment interventions represented a
main effect with respect to contractile performance.
For example, the F values for myocyte percent
shortening and velocity of shortening were signifi-
cant (F 5 118.93, F 5 108.88, p , 0.0001, respec-
tively). More important, this analysis identified a
significant interaction between these two main ef-
fects; specifically, F values of 2.87 and 3.82 were
obtained for myocyte percent shortening and veloc-
ity of shortening (p 5 0.0225 and p 5 0.0044,
respectively). In light of the significant interaction
between the main treatment effects, individual pair-
wise comparisons for indices of myocyte contractility
were performed using Bonferroni confidence inter-
vals constructed from the mean square error ob-
tained from a multiway ANOVA. The results from
these pairwise contrasts and the individual p values
obtained are shown in Table I. Myocyte contractility
increased after b-AR occupancy or adenylate cy-
clase stimulation, but these effects appeared re-
duced compared with normothermic control values.
For example, myocyte velocity of shortening was
reduced by more than 30% after either b-AR occu-
pancy or adenylate cyclase stimulation compared
with respective normothermic control values. Direct
activation of the L-type Ca21 channel increased
myocyte contractility after cardioplegic arrest but
was reduced when compared with the normothermic
control values. For example, myocyte velocity of
shortening was reduced by 37% and 43% compared
with the normothermic control values at the 10
nmol/L and 100 nmol/L (–)BayK 8644 concentra-
tions, respectively.
In light of the significant differences in baseline
contractile function between the normothermic con-
trol myocytes and myocytes after cardioplegic arrest
and rewarming, the effect of b-adrenergic occu-
pancy, adenylate cyclase stimulation, or direct L-type
Ca21 channel activation on myocyte contractile
function may be difficult to interpret. Therefore the
absolute change from baseline for velocity of short-
ening was computed in each myocyte after each
treatment (Fig. 2). Cardioplegic arrest and rewarm-
ing were associated with a significant decrease in
absolute change from baseline in myocyte velocity of
shortening after b-adrenergic occupancy, adenylate
cyclase stimulation, or direct L-type Ca21 channel
activation. Another approach for expressing the
relative contractile response to the individual drug
interventions would be as a percent change from
Fig. 2. Myocyte contractile function in both the normo-
thermic state and after cardioplegic arrest was measured
by absolute change in myocyte shortening velocity after
b-AR (B-AR) occupancy with 25 nmol/L isoproterenol,
stimulation of adenylate cyclase with 0.5 mmol/L forskolin
(AC), or direct activation of the L-type Ca21 channel with
both 10 nmol/L and 100 nmol/L (–)BayK 8644. The
absolute change in shortening velocity after b-receptor
occupancy, stimulation of adenylate cyclase, or direct
activation of the L-type Ca21 channel after cardioplegic
arrest was reduced compared with normothermic values
(p 5 0.012, p 5 0.005, p 5 0.0006, respectively). The
response to 100 nmol/L (–)BayK 8644 was greater than
that to 10 nmol/L (–)BayK 8644 in the normothermic
group (p 5 0.02) and after cardioplegic arrest (p 5
0.0015) as previously predicted by the dose-response study
(*p , 0.05 vs normothermic control, #p , 0.05 vs 10
mol/L (–)BayK 8644; actual p values provided in text).
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steady state basal values. By means of this strategy,
myocyte velocity of shortening was increased by
231% and 304% with b-AR occupancy, by 110%
and 109% with adenylate cyclase stimulation, and by
90% and 85% with Ca21 channel activation (100
nmol/L BayK) in the normothermic control and
hypothermic cardioplegia groups, respectively. Both
analyses revealed that the myocytes retained the
capacity to respond to an inotropic stimulus after
hypothermic cardioplegic arrest. Nevertheless, the
absolute value for indices of contractility remained
significantly blunted in myocytes after cardioplegic
arrest compared with controls after any of the three
drug interventions.
Discussion
Transient LV dysfunction can occur after hypo-
thermic, hyperkalemic cardioplegic arrest and is
associated with decreased b-adrenergic responsive-
ness. The overall goal of this study was to define the
contributory intracellular mechanism(s) potentially
responsible for the defects in the b-adrenergic sig-
naling cascade that occur after cardioplegic arrest.
Under normal conditions, occupancy of the b-ad-
renergic receptor stimulates adenylate cyclase with
subsequent activation of the L-type Ca21 channel.
Activation of this channel increases Ca21 current
thereby enhancing myocyte contractility. Accord-
ingly, this study examined myocyte contractile per-
formance after b-AR occupancy, direct stimulation
of adenylate cyclase, or direct activation of the
L-type Ca21 channel under normothermic condi-
tions and after simulated cardioplegic arrest. The
significant findings of this study were twofold. First,
b-AR occupancy or direct adenylate cyclase stimu-
lation increased myocyte contractility; but the effect
of either was reduced after simulated cardioplegic
arrest. Second, direct activation of the L-type Ca21
channel, which eliminates b-AR dependent events,
increased myocyte contractile performance under
both conditions. However, the myocyte inotropic
response to L-type Ca21 channel activation was
reduced after cardioplegic arrest. These findings
suggest that contributory mechanisms for the re-
duced b-adrenergic response after cardioplegic ar-
rest are downstream from this transduction path-
way.
A schematic representation of the b-adrenergic
signaling cascade is shown in Fig. 3, with emphasis
on the rationale for the experimental design used in
this study. Under normal conditions, occupancy of
the b-AR initiates a signaling cascade involving a
G-protein complex, through which adenylate cyclase
is stimulated to increase production of cAMP. In-
creased intracellular cAMP activates protein kinase
A (PKA), which mediates three important intracel-
lular events. First, PKA phosphorylates the L-type
Ca21 channel, augmenting Ca21 flux across the
sarcolemma and thereby enhancing the release of
intracellular Ca21 stores from the sarcoplasmic re-
ticulum (SR).4, 19, 20 Second, PKA phosphorylates
the SR-bound regulatory protein phospholamban,
which augments intracellular Ca21 resequestration
by the SR.4, 19, 20 Third, PKA phosphorylates tropo-
nin-I, which directly influences myofilament Ca21
sensitivity and therefore cross-bridge formation.4, 21
In this study, myocyte contractile response to b-
adrenergic stimulation was reduced after cardiople-
gic arrest. Additionally, the inotropic response
failed to return to normal levels with either direct
stimulation of adenylate cyclase or direct activation
of the L-type Ca21 channel. These findings suggest
that the decreased myocyte inotropic response to
b-AR stimulation after cardioplegic arrest may be
the result of three intracellular defects. First, dimin-
ished PKA activation may occur with subsequent
defects in phosphorylation of the L-type Ca21 chan-
nel, phospholamban, and troponin-I. Second, the
intracellular homeostatic mechanisms responsible
for release and resequestration of SR Ca21 stores
may be altered. Third, a decrease in the sensitivity of
the contractile apparatus to Ca21 with a subsequent
reduction in cross-bridge formation may occur. Us-
ing this isolated myocyte model of cardioplegic
arrest, future studies that more carefully focus on
these potential intracellular defects with emphasis
on PKA-mediated events are warranted.
The administration of b-AR agonists is a common
means of improving LV pump function after car-
dioplegic arrest and separation from cardiopul-
monary bypass.22 However, diminished inotropic
response to b-adrenergic stimulation after car-
dioplegic arrest has been reported.5-7 Several con-
tributing factors for the reduced inotropic effect of
b-AR stimulation after cardioplegic arrest have
been identified.5-10 For example, Schwinn and col-
leagues6 demonstrated that an uncoupling of the
b-AR with a reduction in adenylate cyclase activity
occurs after cardioplegic arrest.6 Thus in this study
contributory mechanisms for the reduction in con-
tractile response with b-adrenergic occupancy or
adenylate cyclase stimulation may be an uncoupling
of the b-AR with a resultant reduction in adenylate
cyclase activity. Furthermore, this study builds on
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these past findings by demonstrating that signaling
pathway components essential for the b-adrenergic
response (i.e., the L-type Ca21 channel) may also be
affected after cardioplegic arrest. Additional studies
have demonstrated that with the onset of cardiopul-
monary bypass, catecholamine levels increase sev-
eral fold and remain elevated throughout the bypass
period.8, 9 It has been suggested that the persistently
elevated catecholamine levels associated with car-
diopulmonary bypass cause desensitization of the
b-AR with diminished adenylate cyclase activa-
tion.6-8 In this study, an isolated myocyte system of
cardioplegic arrest, which is independent of neuro-
hormonal influences, was used. After simulated
Fig. 3. A schematic representation of the b-adrenergic signaling cascade, with emphasis on the rationale
for the experimental design used in this study. Under normal conditions, occupancy of the b-AR initiates
a signaling cascade involving a G-protein complex, through which adenylate cyclase is stimulated to
increase production of cAMP. Increased intracellular cAMP activates protein kinase A, which mediates
three important intracellular events: (A) phosphorylation of the L-type Ca21 channel, which augments
Ca21 flux across the sarcolemma, enhancing the release of intracellular Ca21 stores from the SR; (B)
phosphorylation of troponin-I, which directly influences myofilament Ca21 sensitivity and thereby
cross-bridge formation; and (C) phosphorylation of the SR-bound regulatory protein phospholamban,
which enhances intracellular Ca21 resequestration by the SR. In this study the b-adrenergic signaling
cascade was examined by pharmacologic dissection at three specific points. First, the b-AR was stimulated
with isoproterenol. Second, adenylate cyclase was stimulated with forskolin. Third, the L-type Ca21 channel
was activated with (–)BayK 8644. After simulated cardioplegic arrest, significant blunting of the inotropic
response to all three treatments compared with normothermic control values was demonstrated. These
results suggest that defects in intracellular Ca21 homeostasis, myofilament Ca21 sensitivity, or both
contribute to the diminished inotropic response after cardioplegic arrest.
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cardioplegic arrest and rewarming, defects in myo-
cyte b-AR responsiveness were observed and are
consistent with past in vivo studies.10 Therefore
increased plasma catecholamine levels alone cannot
explain the decreased b-AR responsiveness that
occurs after cardioplegic arrest and separation from
cardiopulmonary bypass.
Forskolin, a naturally occurring diterpene, has
been shown to directly stimulate adenylate cyclase,
which increases intracellular cAMP,11, 12 effectively
bypassing the b-AR and G-protein complex of the
b-adrenergic signaling cascade. Several past studies
have demonstrated that forskolin produces a posi-
tive inotropic effect in myocardial preparations.11, 12
For example, Bristow and colleagues11 demon-
strated that forskolin increased adenylate cyclase
activity and produced a potent positive inotropic
response in human right ventricular papillary mus-
cle. Hearse and colleagues,12 using an isolated rat
heart model of cardioplegic arrest, demonstrated
that while contractile function was improved and
adenylate cyclase activity was increased in the pres-
ence of forskolin, contractile performance remained
lower than normal control values. Consistent with
these past observations, this study found that the
inotropic response to forskolin was blunted after
cardioplegic arrest. Other past studies have demon-
strated that phosphodiesterase inhibitors, which
prevent the degradation of cAMP, have a positive
inotropic effect after cardiopulmonary bypass with
cardioplegic arrest.23 However, this laboratory has
previously demonstrated that although phosphodi-
esterase inhibition increased isolated myocyte con-
tractility after cardioplegic arrest, the inotropic re-
sponse was blunted compared with normothermic
control values.24 Taken together the findings of this
study and evidence from past reports suggest that
the defect(s) resulting in reduced responsiveness to
b-adrenergic stimulation after cardioplegic arrest
occur downstream from cAMP production in the
signaling cascade. Because one of the important
events after adenylate cyclase activation includes
phosphorylation of the L-type Ca21 channel, this
study next examined the effect of direct activation of
this channel on myocyte contractile function under
normothermic conditions and after simulated car-
dioplegic arrest.
The dihydropyridine derivative, (–)BayK 8644,
binds to the alpha subunit of the L-type Ca21
channel, induces prolonged channel opening, and
thereby increases Ca21 flux through the channel.4, 14
Past studies have demonstrated that (–)BayK 8644
increased contractile function in myocardial prepa-
rations.13, 14 However, to our knowledge, this study
is the first to examine the direct effects of (–)BayK
8644 on the contractile performance of the isolated
myocyte under normothermic conditions and after
simulated cardioplegic arrest. In this study, (–)BayK
8644 elicited a dose-dependent positive inotropic
response consistent with specific activation of the
L-type Ca21 channel in isolated myocytes under
normothermic conditions. After simulated car-
dioplegic arrest, an apparent similar dose-depen-
dent increase in myocyte contractility was noted.
Under both normothermic conditions and after
simulated cardioplegic arrest, total contraction du-
ration was increased by more than 25%. A likely
contributory mechanism for the increased contrac-
tion duration in the presence of (–)BayK 8644 was
alterations in Ca21 homeostatic processes. (–)BayK
8644 increases intracellular Ca21 levels without el-
evating cAMP levels.14 Thus, while intracellular
Ca21 levels rise, basal phospholamban activity and
rate of Ca21 resequestration by the SR remain
unchanged. This net effect would potentially result
in increased cross-bridge release time and pro-
longed elevation in the cytoplasmic Ca21 concentra-
tion that would be translated as an increase in total
contraction duration. Although direct activation of
the L-type Ca21 channel elicited a positive inotropic
response after cardioplegic arrest, this response was
significantly blunted compared with normothermic
control values. A recent study by Lopez and col-
leagues25 demonstrated that a hyperkalemic envi-
ronment increased resting intracellular Ca21 levels
in isolated myocytes. A past study from this labora-
tory demonstrated that the positive inotropic re-
sponse to increased extracellular Ca21 in the iso-
lated myocyte is diminished after cardioplegic
arrest.26 Taken together, results from our study and
past reports suggest that the decrease in myocyte
inotropic response after cardioplegic arrest may
involve defects in intracellular Ca21 handling, use,
or both. Increased intracellular Ca21 accumulation
has been shown to contribute to reoxygenation
injury and decreased recovery of contractile perfor-
mance with reperfusion.27 Alterations in intracellu-
lar Ca21 compartmentalization and sequestration
may occur during and immediately after prolonged
periods of cardioplegic arrest. These persistent de-
fects in Ca21 homeostatic processes within the myo-
cyte after cardioplegic arrest may contribute to the
diminished contractile responsiveness with direct
L-type Ca21 channel activation. The specific abnor-
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malities in intracellular Ca12 compartmentalization
after cardioplegic arrest, particularly with respect to
the function of the SR warrant further study.
Although the isolated myocyte system used in this
study provided a means to pharmacologically dissect
the b-adrenergic signaling cascade to examine spe-
cific defects in contractile mechanisms, several lim-
itations to this in vitro system exist. The model
excludes environmental factors present in vivo, in-
cluding changes in systemic loading conditions and
neurohormonal influences. This model of cardiople-
gic arrest differs with respect to in vivo conditions in
that the myocytes are not subject to variations in
temperature and are continuously exposed to the
hyperkalemic environment. This model of simulated
cardioplegic arrest causes a decrease in myocyte
contractility. However, this decrease in contractile
performance is a transient phenomenon. Specifi-
cally, 30 minutes after reperfusion/rewarming, indi-
ces of myocyte contractile function approach nor-
mothermic values.28 Although this is a limitation of
the model, it does appear to recapitulate the tran-
sient LV dysfunction that may be encountered after
cardioplegic arrest in the clinical setting. Our study
makes the assumption that the response elicited by
(–)BayK 8644 after cardioplegic arrest arises from a
functionally intact L-type Ca21 channel. Whether
cardioplegic arrest causes direct negative effects to
the L-type Ca21 channel with respect to functional
state is unknown. Future studies measuring the
Ca21 current through the L-type Ca21 channel in the
presence and absence of (–)BayK 8644 in the nor-
mothermic state and after cardioplegic arrest would
be necessary to address this issue. It should also be
understood that this study was conducted using
asanguineous cardioplegia and cell media and that
results in a blood-perfused in vivo preparation may
result in differential findings with respect to the
b-adrenergic signaling cascade.
The findings of this study open avenues for future
studies aimed at identifying other possible sites in
the b-adrenergic signaling cascade that may be
affected by cardioplegic arrest. Specifically, future
studies examining the role of PKA-mediated intra-
cellular events on myocyte contractile performance
after cardioplegic arrest are warranted. An increas-
ing number of patients are presenting for cardiac
surgery with preexisting LV dysfunction,29 a condi-
tion that has been associated with decreased sensi-
tivity and inotropic response to b-adrenergic stimu-
lation.30 Thus direct activation of the L-type Ca21
channel may prove beneficial as a therapeutic mo-
dality in this subset of patients. However, future in
vitro and in vivo studies would be required to
examine this hypothesis. Nevertheless, the findings
of this study support the conclusion that defect(s)
contributing to decreased inotropic responsiveness
in isolated myocytes after cardioplegic arrest may
include defects in the b-AR signaling cascade,
disturbances in intracellular Ca21 homeostasis,
changes in myofilament Ca21 sensitivity, or any com-
bination of the above.
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